PUBLICATIONS

  • A.L. JENNERL, R. AOGO, S. ALFONSO, V. CROWE, A.P. SMITH, P.A. MOREL, C.L. DAVIS, A.M. SMITH, M. CRAIG (2020), "COVID-19 virtual patient cohort reveals immune mechanisms driving disease outcomes" PLOS Pathogens (accepted 2021)

  • P. CROSLEY, A. FARKKILA, A.L. JENNER, ..... M. CRAIG, ... M.M. HITT (2020), "Procaspase-activating compound-1 synergizes with TRAIL to induce apoptosis in established granulosa cell tumour cell line (KGN) and primary granulosa cell tumour cells in vitro" International Journal of Molecular Sciences (accepted 2021)

  • Y. WANG, G. AN, A. BECKER, M. CRAIG,.... A.L. JENNER.....P. MACKLIN (2020), "Rapid community-driven development of a SARS-CoV-2 tissue simulator" BioRxiv

  • A.L. JENNER, T. CASSIDY, K. BELAID, M.C. BOURGEOIS-DAIGNEAULT, M. CRAIG (2020), “In silico trails predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumour aggressivity”, Journal for ImmunoTherapy of Cancer (accepted for publication Dec 2020)

  • S. ALFONSA, A.L. JENNER, M.CRAIG (2020), “Translational approaches to treating dynamical diseases through in silico clinical trails”, Chaos: An interdisciplinary Journal of Nonlinear Science 30:123128

  • M. CRAIG, A.L. JENNER, B. NAMGUNG, L. LEE, A. GOLDMAN (2020), “Engineering in Medicine to address the challenge of cancer drug resistance: From micro- and nanotechnologies to computational and mathematical modelling”, Chemical Reviews

  • A.L. JENNER, R.A. AOGO, C.L. DAVIS, A.M. SMITH, M. CRAIG (2020), “Leveraging Computational Modelling to Understand Infectious Diseases”, Current Pathobiology 1-13

  • A.L. JENNER, F. FRASCOLI, C.O. YUN, P.S. KIM (2020), “Optimising Hydrogel Release Profiles for Viro-Immunotherapy Using Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Immature Dendritic Cells”, Applied Science 10(8):2872

  • T. LEE, A.L. JENNER, P.S. KIM, J.LEE (2020), “Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy”, Mathematical Biosciences and Engineering 17(3): 2361

  • A.L. JENNER, F. FRASCOLI, A.C.F. COSTER, P.S. KIM (2019), “Enhancing oncolytic virotherapy: Observations from a Voronoi Cell-Based model”, Journal of Theoretical Biology 485: 110052

  • A.L. JENNER, P.S. KIM, F. FRASCOLI (2019), “Oncolytic virotherapy for tumours following a Gompertz growth law”, Journal of Theoretical Biology 480: 129-140

  • A.L. JENNER (2019), “Applications of Mathematical Modelling in Oncolytic Virotherapy and Immunotherapy”, University of Sydney

  • A.L. JENNER, C.O. YUN, A. YOON, P.S. KIM, A.C.F. COSTER (2018), “Modelling heterogeneity in viral-tumour dynamics: The effects of gene-attenuation on viral characteristics”, Journal of Theoretical Biology 454: 41-52

  • A.L. JENNER, A.C.F. COSTER, P.S. KIM, F. FRASCOLI (2018), “Treating cancerous cells with viruses: insights from a minimal model for oncolytic virotherapy”, Letters in Biomathematics 5(sup1): S117-S136

  • A.L. JENNER, C.O. YUN, P.S. KIM, A.C.F. COSTER (2018), “Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols”, Bulletin of Mathematical Biology 80(6): 1615-1629